Analysis of the microbial spectrum of urinary tract infections and antibiotic resistance of UPEC in Central Inner Mongolia, China
Abstract
Urinary Tract Infections (UTIs) remain a significant global health concern, with the pathogen spectrum and antibiotic resistance patterns critically influencing clinical management. This study aimed to analyze the microbial profile of UTIs from 2022 to 2024, focusing on Escherichia coli (E. coli), the predominant pathogen, by evaluating its antibiotic resistance phenotypes, biofilm formation capability, and mutations in GyrA, ParC and Plasmid-Mediated Quinolone Resistance (PMQR) genes prevalence. Midstream urine samples from UTI patients were collected and analyzed for microbial identification. E. coli isolates were tested for antibiotic susceptibility, particularly to levofloxacin, the most frequently used antibiotic in our hospital. Biofilm formation was assessed, and mutations in GyrA, ParC and PMQR genes were sequenced to determine resistance mechanisms.The pathogen spectrum revealed that Enterobacteriaceae were the most prevalent (44.42%), with E. coli being the dominant species. Over 70% of E. coli isolates exhibited resistance to levofloxacin, and 58.97% (46/78) demonstrated biofilm-forming ability. Among levofloxacin-resistant strains, 75.64% (59/78) showed high-level resistance (MIC ≥ 8μg/mL). The most common mutations in GyrA were Ser83Leu (89.74%) and Asp87Asn (71.79%), while Ser80Ile (74.36%) was predominant in ParC. PMQR genes were detected in 17.95% (14/78) of isolates. The elevated prevalence of quinolone-resistant E. coli in urinary tract infections within…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.